Rhythm Pharmaceuticals (RYTM) is up 11.4%, or $11.97 to $116.74.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYTM:
- Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
- Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial
- Brinker upgraded, Coinbase downgraded: Wall Street’s top analyst calls
- Rhythm Pharmaceuticals initiated with a Buy at Citi
- Rhythm announces presentation of four datasets at ObesityWeek